{"&cites=14686919953850908529&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Cancer treatment and survivorship statistics, 2016","url":"https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.3322/caac.21349","authors":["KD Miller","KD Miller RL Siegel","KD Miller RL Siegel CC Lin…"],"year":2016,"numCitations":3382,"pdf":"https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21349","citationUrl":"http://scholar.google.com/scholar?cites=15245493793785177953&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Yef809TfktMJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15245493793785177953&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library","p":1,"exp":1596876794858},{"title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1301689","authors":["Cancer Genome Atlas Research …"],"year":2013,"numCitations":2570,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1301689","citationUrl":"http://scholar.google.com/scholar?cites=10366841723230819589&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:BRXfE59r3o8J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10366841723230819589&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","url":"https://ashpublications.org/blood/article-abstract/129/4/424/36196","authors":["H Döhner","H Döhner E Estey","H Döhner E Estey D Grimwade","H Döhner E Estey D Grimwade S Amadori…"],"year":2017,"numCitations":1799,"pdf":"https://ashpublications.org/blood/article/129/4/424/36196","citationUrl":"http://scholar.google.com/scholar?cites=10140419055570643731&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:E-vjoGcBuowJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10140419055570643731&hl=en&as_sdt=2005&sciodt=0,5","publication":"ashpublications.org"},{"title":"Genomic classification and prognosis in acute myeloid leukemia","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1516192","authors":["E Papaemmanuil","E Papaemmanuil M Gerstung","E Papaemmanuil M Gerstung L Bullinger…"],"year":2016,"numCitations":1507,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1516192","citationUrl":"http://scholar.google.com/scholar?cites=7666846223862507354&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:WqfeGAUcZmoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7666846223862507354&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Acute myeloid leukemia","url":"https://www.nejm.org/doi/full/10.1056/NEJMra1406184","authors":["H Döhner","H Döhner DJ Weisdorf…"],"year":2015,"numCitations":1492,"pdf":"http://www.christimres.com/uploads/7/0/7/6/70764707/acute_myeloid_leukemia.pdf","citationUrl":"http://scholar.google.com/scholar?cites=6855405639761745746&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Ulc1nRtLI18J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6855405639761745746&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine …","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4874148/","authors":["HM Kantarjian","HM Kantarjian XG Thomas","HM Kantarjian XG Thomas A Dmoszynska…"],"year":2012,"numCitations":789,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4874148/","citationUrl":"http://scholar.google.com/scholar?cites=5395723740288186750&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:fvkEbid24UoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5395723740288186750&hl=en&as_sdt=2005&sciodt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Therapeutic advances in acute myeloid leukemia","url":"http://pgcmehematology.net/articles/008-treatment-AML.pdf","authors":["A Burnett","A Burnett M Wetzler","A Burnett M Wetzler B Lowenberg"],"year":2011,"numCitations":755,"pdf":"http://pgcmehematology.net/articles/008-treatment-AML.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15339441990549548661&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:da5q8zel4NQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15339441990549548661&hl=en&as_sdt=2005&sciodt=0,5","publication":"pgcmehematology.net"},{"title":"IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia …","url":"https://ascopubs.org/doi/abs/10.1200/jco.2010.28.3762","authors":["P Paschka","P Paschka RF Schlenk","P Paschka RF Schlenk VI Gaidzik…"],"year":2010,"numCitations":739,"pdf":"/scholar?output=instlink&q=info:4X2Jr-sTWeQJ:scholar.google.com/&hl=en&as_sdt=2005&sciodt=0,5&scillfp=10428608273474215314&oi=lle","citationUrl":"http://scholar.google.com/scholar?cites=16454204616558083553&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:4X2Jr-sTWeQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16454204616558083553&hl=en&as_sdt=2005&sciodt=0,5","publication":"ascopubs.org"},{"title":"IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia …","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2881719/","authors":["G Marcucci","G Marcucci K Maharry","G Marcucci K Maharry YZ Wu…"],"year":2010,"numCitations":730,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2881719/","citationUrl":"http://scholar.google.com/scholar?cites=14886713428219831192&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:mKMUYv06mM4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14886713428219831192&hl=en&as_sdt=2005&sciodt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1614359","authors":["RM Stone","RM Stone SJ Mandrekar","RM Stone SJ Mandrekar BL Sanford…"],"year":2017,"numCitations":735,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1614359","citationUrl":"http://scholar.google.com/scholar?cites=16707249534232810446&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ztPBve4S3OcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16707249534232810446&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"}]}